查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2086198

食品動物非治療性抗生素市場：依動物種類、產品類型、劑型、給藥途徑、最終用途及銷售管道分類－2026-2032年全球市場預測

Non-Therapeutic Antibiotics for Food Animals Market by Animal Type, Product Type, Formulation, Application Mode, End Use, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，肉類生產牲畜非治療性抗生素市場規模將成長至 95.5 億美元，複合年成長率為 7.27%。

主要市場統計數據
基準年 2025 58.4億美元
預計年份：2026年 62.4億美元
預測年份 2032 95.5億美元
複合年成長率 (%) 7.27%

非治療性抗生素用於食用動物是指將抗菌劑用於治療已確診疾病以外的其他目的，例如促進生長、提高飼料轉換率和預防常見疾病。由於這一類別涉及食品安全、畜牧生產力、抗菌素抗藥性和國際貿易合規性等多個方面，因此在動物健康領域仍受到嚴格監管。

世界衛生組織、聯合國糧農組織和世界動物衛生組織發布的檢驗的公共衛生指南繼續在「同一健康」框架下優先考慮畜牧業中合理使用抗生素。隨著監管機構限制將具有重要醫療價值的抗生素用於生產目的，行業價值觀正從以數量為導向的抗生素消費轉向獸醫監管、診斷、疫苗接種、生物安全、營養改善和抗生素替代方案。

市場狀況的變革性變化

最重要的結構性變化體現在監管方面。歐盟於2006年禁用抗菌生長促進劑，美國於2017年實施了獸用飼料指令（VFD），2023年，美國食品藥品監督管理局（FDA）發布的第263號產業指南將剩餘的非處方、具有重要醫療價值的獸用抗菌劑重新歸類為處方箋藥。加拿大、中國和其他幾個主要生產國也加強了對生長促進劑標籤、藥用飼料添加劑和獸醫核准的監管。

人工智慧（AI）的累積影響

人工智慧 (AI) 正在加速從常規、非治療性抗生素使用到精準動物健康管理的轉變。人工智慧驅動的感測器、電腦視覺、聲學監測、熱成像和預測分析技術能夠在疾病擴散到整個群體之前，檢測到飼料量、活動量、體溫、咳嗽、行為或死亡模式的變化。

對關鍵區域的洞察

亞太地區是畜牧業生產的主要成長區域，中國、印度、東南亞、日本、韓國和澳洲是主要驅動力，但各國控制力道不一。中國實施了多項嚴格限制措施，包括禁止使用粘菌素作為生長促效劑，以及對藥用飼料添加劑制定更嚴格的規定。同時，澳洲和日本擁有高度完善的獸醫監管體系和食品安全管理系統。在印度和東南亞國協，隨著動物性蛋白質需求的成長，人們越來越重視殘留物控制、農場生物安全和監測。

關鍵小組洞察

東南亞國協正努力平衡快速成長的動物性蛋白質需求與不斷完善的獸醫管治，這使得該地區成為抗生素替代品、飼料添加劑、疫苗接種計劃和監測平台的重要市場。海灣合作理事會（GCC）國家雖然嚴重依賴食品進口，但它們也在投資國內家禽、乳製品、水產養殖和生物安全體系，從而催生了對符合規範的動物衛生規程和殘留物管理方案的需求。

主要國家的概況

美國、加拿大和墨西哥的特點是獸醫監管嚴格、肉類供應鏈一體化，並且對出口合規性要求較高。美國尤其注重處方管理、藥用飼料授權以及抗菌藥物的年度銷售報告。巴西仍然是全球牛肉和家禽貿易中心，該國對抗菌藥物的管理日益重視，體現在對殘留限量、市場進入和買家標準的遵守等方面。英國、德國、法國、義大利和西班牙均在符合歐洲標準的嚴格框架下運作。德國和法國在抗菌藥物減量計劃方面歷來發揮重要作用，而西班牙則實施了一項國家行動計劃，顯著降低了獸用抗菌藥物的使用量。

為行業領導者提供的實用建議

產業領導者應將減少非治療性抗生素的使用視為提升競爭力的策略，而非僅將其視為合規負擔。優先事項應包括：實施由獸醫主導的合理抗菌藥物使用計劃；按物種和生產階段對抗菌藥物使用情況進行基準分析；改進疾病風險評估；以及以疫苗接種、診斷、生物安全、注重動物福利的飼養環境和營養為基礎的健康計劃，取代常規預防措施。

調查方法

本研究採用基於三角測量的調查方法，整合了公共監管資料庫、獸用抗菌藥物銷售報告、國家政策文件、同行評審文獻、貿易數據、食品安全指南和專家檢驗。主要參考文獻包括世界衛生組織、聯合國糧農組織、世界動物衛生組織、美國食品藥物管理局、歐洲藥品管理局、歐洲獸醫和動物保健局、歐洲食品安全局、歐洲疾病預防控制中心、加拿大衛生署、各國農業部和獸醫主管部門。

結論

肉類畜牧業中非治療性抗生素的使用正在經歷長期的結構性調整。生長促進型抗生素的使用以及常規預防性使用具有重要醫療價值的抗生素正日益受到法規、消費者期望、零售標準、食品安全要求和抗菌素抗藥性政策的限制。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 食用動物非治療性抗生素市場：依動物類型分類

  • 水產養殖
  • 牛
  • 家禽
  • 豬

第8章 食用動物非治療性抗生素市場：依產品類型分類

  • Aminoglycosides抗生素
    • 慶大霉素
    • 新黴素
    • 鏈黴素
  • 大環內酯類
    • 紅黴素
    • 替爾米科辛
    • 泰樂菌素
  • 青黴素類
    • 阿莫西林
    • Ampicillin
    • 青黴素G
  • 磺胺類藥物藥物
    • 磺胺嘧啶
    • 磺胺二甲嗪
    • 磺胺甲噁唑
  • 四環黴素
    • 四環黴素
    • 四環黴素
    • 四環黴素

第9章 食用動物非治療性抗生素市場：以劑型分類

  • 飼料添加劑
  • 口服懸浮液
  • 水溶性粉末

第10章 食用動物非治療性抗生素市場：依應用類型分類

  • 飼料添加
  • 水下管理

第11章 食用動物非治療性抗生素市場：依最終用途分類

  • 促進生長
  • 預防

第12章 食用動物非治療性抗生素市場：依銷售管道分類

  • 飼料廠
  • 零售藥房
  • 獸藥批發商

第13章 食用動物非治療性抗生素市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 食用動物非治療性抗生素市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 食用動物非治療性抗生素市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • AdvaCare Pharma
  • Ashish Life Science Pvt. Ltd.
  • Bimeda Holdings Limited
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale SA
  • Chanelle Pharma
  • China Animal Husbandry Industry Co., Ltd.
  • Dechra Pharmaceuticals PLC
  • ECO Animal Health Group Plc
  • Elanco Animal Health Incorporated
  • Endovac Animal Health
  • Hester Biosciences Ltd.
  • HIPRA, SA
  • Huvepharma SA
  • Indian Immunologicals Ltd.
  • Inovet Group
  • Intas Pharmaceuticals Ltd.
  • Kyoritsu Seiyaku Corporation
  • Meiji Holdings Co., Ltd.
  • Merck & Co., Inc.
  • Norbrook Laboratories Limited
  • Ouro Fino Saude Animal
  • Phibro Animal Health Corporation
  • SeQuent Scientific Ltd.
  • Vetoquinol SA
  • Vetsfarma Ltd.
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-036C5CF3B529

The Non-Therapeutic Antibiotics for Food Animals Market is projected to grow by USD 9.55 billion at a CAGR of 7.27% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.84 billion
Estimated Year [2026] USD 6.24 billion
Forecast Year [2032] USD 9.55 billion
CAGR (%) 7.27%

Non-therapeutic antibiotics for food animals include antimicrobial use for growth promotion, feed efficiency, and routine disease prevention rather than treatment of a diagnosed illness. This category remains a high-scrutiny segment of animal health because it sits at the intersection of food security, livestock productivity, antimicrobial resistance, and global trade compliance.

Verified public-health guidance from WHO, FAO, and WOAH continues to prioritize responsible antimicrobial use in livestock under the One Health framework. As regulators restrict medically important antibiotics for production purposes, industry value is shifting from volume-led antibiotic consumption toward veterinary oversight, diagnostics, vaccination, biosecurity, improved nutrition, and antibiotic alternatives.

Transformative Shifts in the Market Landscape

The most important structural shift is regulatory. The European Union banned antibiotic growth promoters in 2006, the United States implemented the Veterinary Feed Directive in 2017, and FDA Guidance for Industry 263 brought remaining over-the-counter medically important animal antibiotics under veterinary prescription status in 2023. Canada, China, and several other major producers have also tightened controls on growth-promotion claims, medicated feed additives, and veterinary authorization.

Commercial strategies are therefore moving away from routine antibiotic inputs and toward integrated herd and flock health management. Producers are investing in vaccination, nutrition, probiotics, prebiotics, enzymes, improved housing, manure management, and disease surveillance to protect productivity while meeting retailer, exporter, and consumer expectations for antibiotic stewardship.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is accelerating the transition from routine non-therapeutic antibiotic use to precision animal health management. AI-enabled sensors, computer vision, acoustic monitoring, thermal imaging, and predictive analytics can detect changes in feed intake, mobility, body temperature, coughing, behavior, or mortality patterns before disease spreads across a herd or flock.

The cumulative impact is a more data-driven operating model for livestock production. AI supports targeted veterinary intervention, antimicrobial use benchmarking, resistance surveillance, welfare monitoring, and audit-ready compliance documentation. Adoption depends on data quality, farm connectivity, validated algorithms, cybersecurity, and integration with veterinary workflows, but the direction is clear: AI reduces reliance on blanket prevention and strengthens evidence-based antibiotic stewardship.

Key Regional Insights

Asia-Pacific is a major livestock-production growth arena, led by China, India, Southeast Asia, Japan, South Korea, and Australia, but stewardship intensity varies by country. China has implemented major restrictions, including the prohibition of colistin as a growth promoter and tighter rules on medicated feed additives, while Australia and Japan maintain highly structured veterinary oversight and food-safety controls. India and ASEAN economies are increasingly focused on residue control, farm biosecurity, and surveillance as animal protein demand rises.

North America is shaped by mature regulation and transparent sales reporting, with U.S. FDA summaries showing substantial declines in medically important antimicrobial sales for food-producing animals compared with the 2015 peak. Europe remains the global benchmark for reduction policy, supported by ESVAC reporting and the EU Farm to Fork target to cut antimicrobial sales for farmed animals and aquaculture by 50% by 2030 versus 2018. Latin America is advancing stewardship through export-driven compliance, particularly in poultry, beef, and pork supply chains, while the Middle East is strengthening biosecurity and veterinary controls in intensive poultry and dairy systems. Africa faces higher variability in veterinary access, diagnostics, and enforcement, making capacity building, surveillance, and responsible-use education central to reducing non-therapeutic antibiotic dependence.

Key Group Insights

ASEAN markets are balancing fast-rising animal protein demand with improving veterinary governance, making the region important for antibiotic alternatives, feed additives, vaccination programs, and surveillance platforms. GCC countries rely heavily on food imports but are investing in domestic poultry, dairy, aquaculture, and biosecurity systems, creating demand for compliant animal-health protocols and residue-control programs.

The European Union leads through legally binding restrictions, harmonized monitoring, and measurable antimicrobial-reduction targets. BRICS countries represent major livestock output and policy diversity, with China, India, Brazil, Russia, and South Africa influencing global production practices, feed systems, and export requirements. G7 markets are driving retailer standards, traceability, AMR policy, and transparent antimicrobial-use reporting, while NATO economies overlap with many high-compliance veterinary medicine markets where food-system resilience, biosecurity, and supply-chain assurance are strategic priorities.

Key Country Insights

The United States, Canada, and Mexico are defined by veterinary oversight, integrated meat supply chains, and export-sensitive compliance, with the United States emphasizing prescription control, medicated feed authorization, and annual antimicrobial sales reporting. Brazil remains central to global beef and poultry trade, making antimicrobial stewardship increasingly relevant to residue compliance, market access, and buyer standards. The United Kingdom, Germany, France, Italy, and Spain operate under strict European-aligned frameworks, with Germany and France historically influential in antimicrobial reduction programs and Spain implementing national action plans that have reported major reductions in veterinary antimicrobial consumption.

China and India are pivotal because of livestock scale, disease pressure, and evolving regulation; China has moved aggressively on feed-additive restrictions, while India's priorities include residue monitoring, poultry and dairy health management, and expanded veterinary capacity. Japan, South Korea, and Australia combine strong food-safety systems with high consumer expectations and structured veterinary controls. Russia remains important in poultry and pork self-sufficiency, while country-specific enforcement, veterinary capacity, antimicrobial-use reporting, and on-farm biosecurity continue to shape adoption of non-antibiotic prevention strategies across all major producing nations.

Actionable Recommendations for Industry Leaders

Industry leaders should treat non-therapeutic antibiotic reduction as a competitiveness strategy rather than a compliance burden. Priority actions include implementing veterinary-led antimicrobial stewardship plans, benchmarking usage by species and production stage, improving disease-risk mapping, and replacing routine prevention with vaccination, diagnostics, biosecurity, welfare-focused housing, and nutrition-based health programs.

Companies should also strengthen supplier audits, digital traceability, residue-control systems, and resistance-risk reporting to meet retailer and export-market expectations. Investment in AI-enabled disease detection, farm data interoperability, workforce training, and validated antibiotic alternatives can protect productivity while reducing regulatory, reputational, and market-access risk.

Research Methodology

The research applies a triangulated methodology that integrates public regulatory databases, veterinary antimicrobial sales reports, national policy documents, peer-reviewed literature, trade data, food-safety guidance, and expert validation. Key reference sources include WHO, FAO, WOAH, FDA, EMA ESVAC, EFSA, ECDC, Health Canada, national agriculture ministries, and veterinary authorities.

The analysis evaluates regulatory direction, livestock production patterns, antimicrobial-use reporting, residue-control requirements, supply-chain standards, retailer commitments, and adoption of antibiotic alternatives. Findings are cross-checked across primary and secondary sources to ensure accuracy, market relevance, and consistency with verified public data while avoiding unsupported assumptions, market sizing, or forecasting.

Conclusion

The non-therapeutic antibiotics for food animals landscape is undergoing a long-term structural reset. Growth-promotion use and routine preventive administration of medically important antibiotics are increasingly constrained by regulation, consumer expectations, retailer standards, food-safety requirements, and antimicrobial-resistance policy.

Future value will concentrate in systems that maintain animal health without routine antibiotic dependence. Producers, animal-health suppliers, feed manufacturers, integrators, and retailers that combine stewardship, diagnostics, vaccination, AI-enabled monitoring, biosecurity, and transparent reporting will be best positioned for compliant and resilient growth.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Non-Therapeutic Antibiotics for Food Animals Market, by Animal Type

  • 7.1. Aquaculture
  • 7.2. Cattle
  • 7.3. Poultry
  • 7.4. Swine

8. Non-Therapeutic Antibiotics for Food Animals Market, by Product Type

  • 8.1. Aminoglycosides
    • 8.1.1. Gentamicin
    • 8.1.2. Neomycin
    • 8.1.3. Streptomycin
  • 8.2. Macrolides
    • 8.2.1. Erythromycin
    • 8.2.2. Tilmicosin
    • 8.2.3. Tylosin
  • 8.3. Penicillins
    • 8.3.1. Amoxicillin
    • 8.3.2. Ampicillin
    • 8.3.3. Penicillin G
  • 8.4. Sulfonamides
    • 8.4.1. Sulfadiazine
    • 8.4.2. Sulfamethazine
    • 8.4.3. Sulfamethoxazole
  • 8.5. Tetracyclines
    • 8.5.1. Chlortetracycline
    • 8.5.2. Oxytetracycline
    • 8.5.3. Tetracycline

9. Non-Therapeutic Antibiotics for Food Animals Market, by Formulation

  • 9.1. Feed Additives
  • 9.2. Oral Suspensions
  • 9.3. Water Soluble Powders

10. Non-Therapeutic Antibiotics for Food Animals Market, by Application Mode

  • 10.1. In Feed
  • 10.2. In Water

11. Non-Therapeutic Antibiotics for Food Animals Market, by End Use

  • 11.1. Growth Promotion
  • 11.2. Prophylaxis

12. Non-Therapeutic Antibiotics for Food Animals Market, by Sales Channel

  • 12.1. Feed Mills
  • 12.2. Retail Pharmacies
  • 12.3. Veterinary Distributors

13. Non-Therapeutic Antibiotics for Food Animals Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Non-Therapeutic Antibiotics for Food Animals Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Non-Therapeutic Antibiotics for Food Animals Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. AdvaCare Pharma
  • 17.2. Ashish Life Science Pvt. Ltd.
  • 17.3. Bimeda Holdings Limited
  • 17.4. Boehringer Ingelheim International GmbH
  • 17.5. Ceva Sante Animale S.A.
  • 17.6. Chanelle Pharma
  • 17.7. China Animal Husbandry Industry Co., Ltd.
  • 17.8. Dechra Pharmaceuticals PLC
  • 17.9. ECO Animal Health Group Plc
  • 17.10. Elanco Animal Health Incorporated
  • 17.11. Endovac Animal Health
  • 17.12. Hester Biosciences Ltd.
  • 17.13. HIPRA, S.A.
  • 17.14. Huvepharma S.A.
  • 17.15. Indian Immunologicals Ltd.
  • 17.16. Inovet Group
  • 17.17. Intas Pharmaceuticals Ltd.
  • 17.18. Kyoritsu Seiyaku Corporation
  • 17.19. Meiji Holdings Co., Ltd.
  • 17.20. Merck & Co., Inc.
  • 17.21. Norbrook Laboratories Limited
  • 17.22. Ouro Fino Saude Animal
  • 17.23. Phibro Animal Health Corporation
  • 17.24. SeQuent Scientific Ltd.
  • 17.25. Vetoquinol S.A.
  • 17.26. Vetsfarma Ltd.
  • 17.27. Virbac S.A.
  • 17.28. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AQUACULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AQUACULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AQUACULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GENTAMICIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GENTAMICIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GENTAMICIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEOMYCIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEOMYCIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEOMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL STREPTOMYCIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL STREPTOMYCIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL STREPTOMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MACROLIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MACROLIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MACROLIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ERYTHROMYCIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ERYTHROMYCIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ERYTHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL TILMICOSIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL TILMICOSIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TILMICOSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL TYLOSIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL TYLOSIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL TYLOSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PENICILLINS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PENICILLINS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PENICILLINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AMOXICILLIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AMOXICILLIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AMOXICILLIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AMPICILLIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AMPICILLIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AMPICILLIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PENICILLIN G MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PENICILLIN G MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PENICILLIN G MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SULFONAMIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SULFONAMIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SULFONAMIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SULFADIAZINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SULFADIAZINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SULFADIAZINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SULFAMETHAZINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SULFAMETHAZINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SULFAMETHAZINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SULFAMETHOXAZOLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SULFAMETHOXAZOLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SULFAMETHOXAZOLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL TETRACYCLINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL TETRACYCLINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL TETRACYCLINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CHLORTETRACYCLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CHLORTETRACYCLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CHLORTETRACYCLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL OXYTETRACYCLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL OXYTETRACYCLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL OXYTETRACYCLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL TETRACYCLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL TETRACYCLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL TETRACYCLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FEED ADDITIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FEED ADDITIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL FEED ADDITIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ORAL SUSPENSIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ORAL SUSPENSIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ORAL SUSPENSIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL WATER SOLUBLE POWDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL WATER SOLUBLE POWDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL WATER SOLUBLE POWDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL IN FEED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL IN FEED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL IN FEED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL IN WATER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL IN WATER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL IN WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL GROWTH PROMOTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL GROWTH PROMOTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL GROWTH PROMOTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PROPHYLAXIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PROPHYLAXIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PROPHYLAXIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL FEED MILLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL FEED MILLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL FEED MILLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY DISTRIBUTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY DISTRIBUTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 200. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 201. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2032 (USD MILLION)
  • TABLE 202. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 203. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 204. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 205. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 207. GCC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 232. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 236. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 237. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2032 (USD MILLION)
  • TABLE 238. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 239. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 240. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 241. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 242. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 243. G7 NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 244. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 248. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 249. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2032 (USD MILLION)
  • TABLE 250. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 251. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 252. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 253. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 254. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 255. NATO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 256. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 269. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 273. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 274. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2032 (USD MILLION)
  • TABLE 275. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 276. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 277. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 278. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 279. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 280. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 281. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 282. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 285. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 286. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2032 (USD MILLION)
  • TABLE 287. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 288. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 289. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 290. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 291. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 292. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 293. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 294. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 297. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 298. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2032 (USD MILLION)
  • TABLE 299. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 300. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 301. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 302. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 303. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 304. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLINS, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED KINGDOM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED KINGDOM NON-THERAPEUTIC